Iranian Journal of Medical Sciences

Blastic Plasmacytoid Dendritic Cell Neoplasm; A Report of Three Cases

Document Type : Case Report(s)

Authors

Department of Hematopathology, Molecular Pathology and Cytogenetics, Shiraz University of Medical Sciences, Shiraz, Iran

Abstract
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematodermic myeloid malignancy that is known to be derived from plasmacytoid dendritic cells which are characterized by expression of CD4, CD56, and more specific markers such as CD123. Here, the authors present three cases of BPDCN diagnosed in the past two years and address different available diagnostic modalities such as morphology, immunohistochemistry, flow cytometry, and cytogenetics. Overall, we believe that although BPDCN is a rare diagnosis, it should not be left unchecked. Currently, available immunophenotyping markers are of great help, but the main clue to figure out the problem of BPDCN is clinicopathologic suspicion.

Keywords


Volume 44, Issue 1 - Serial Number 1
97
January 2019
Pages 74-78


  • Received 22 December 2017
  • Revised 22 July 2019
  • Accepted 22 January 2019

Article View 11,450
PDF Download 3,645